News | Breast Imaging | March 14, 2017

Hologic Showcases New Breast Cancer Screening and Interventional Solutions at ECR 2017

Company highlighted Affirm prone breast biopsy system, Lateral Arm accessory for upright biopsy

Hologic, ECR 2017, breast cancer screening solutions, Affirm prone biopsy system

The Affirm prone biopsy system. Image courtesy of Hologic.

March 14, 2017 — Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new solutions for biopsy workflow, at the European Congress of Radiology (ECR) in Vienna, Austria, March 1-5. The company also hosted a symposium and several educational workshops throughout the show, giving attendees opportunities to experience screening and interventional products that offer unique patient and user benefits and address workflow challenges. 

Since its European launch at ECR in 2016, the Affirm prone system — what the company calls the first dedicated prone biopsy system that is upgradable to allow 3-D imaging-guided breast biopsies — has experienced positive clinical and patient feedback, with more than 95 percent of patients indicating in a post-procedure survey that the biopsy experience was faster, more comfortable and less painful than expected. The system provides clinicians with added confidence through high-quality imaging, 2-D and 3-D biopsy capability, faster and easier workflow, and seamless, 360-degree access to the breast.  

In addition to the Affirm prone system, Hologic featured a number of other products at ECR, including:

  • The Affirm upright biopsy system for the Selenia Dimensions mammography system;  
  • The new Affirm Lateral Arm accessory for upright biopsy, to improve access to challenging lesion locations and provide additional patient positioning options;
  • Eviva and ATEC breast biopsy systems, designed to conduct minimally invasive biopsy procedures under stereotactic, tomosynthesis, ultrasound or magnetic resonance imaging (MRI) guidance;
  • I-View software for contrast-enhanced digital mammography provides functional imaging information and highly detailed 2-D images that can be combined with Hologic’s 3-D Mammography exam images; 
  • Low-dose 3-D Mammography exams with C-View software, delivering high-end clinical performance to 2-D mammography for all breast types in a faster, more comfortable and lower dose exam; and
  • The Horizon bone densitometry (DXA) system, a single platform for osteoporosis and body composition testing or assessment.

Hologic held the following events at ECR: 

  • Symposium: A Paradigm Shift in Breast Biopsy Clinical Practice: A European Perspective, featuring Dr. Shirley Go, Dr. Gianfranco Scaperrotta and Dr. Alejandro Tejerina;
  • Eight educational workshops on the use and optimization of clinical practice with 3-D Mammography exams and C-View software, the use of I-View software, and new solutions that optimize VABB workflow and patient comfort 

For more information: www.hologic.com

Related Content

Mammography, which is an X-ray picture of the breast, is efficient also for women over the age of 70.

Getty Images

News | Mammography | October 22, 2020
October 22, 2020 — ...
Rebrand reflects Volpara Health's mission to prevent advanced-stage breast cancer
News | Breast Imaging | October 19, 2020
October 19, 2020 — Volpara Solutions, a leader in AI-powered breast density assessment, announced that it has changed
More than 600,000 women die of advanced breast cancer annually. (1) There is a safe, universally obtainable method to reduce this terrible toll according to MammaCare Foundation scientist Mark Kane Goldstein, Ph.D.

Module 1

News | Women's Health | October 15, 2020
October 15, 2020 — More than 600,000 women die of advanced breast cancer annually. ...
Released in the lead up to #DenseBreastDay (30 September) and Breast Cancer Awareness Month (October), the animation explains how breast density can complicate mammogram screening and make it harder for medical professionals to detect breast cancer. This highly engaging animation shows a polar bear hiding in a snow globe as an analogy for cancer hiding in dense breast tissue. 

Image provided by Dilon

News | Breast Density | October 07, 2020
October 7, 2020 — A group of Australia’s leading breast can...
Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm.

Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm. Getty Images

News | Breast Imaging | October 05, 2020
October 5, 2020 — A major study of women with ductal carcinoma in situ (...